Advanced Medical Isotope Research and Development Expenses 2013-2024 | RDGL

Advanced Medical Isotope research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Advanced Medical Isotope Research and Development Expenses 2013-2024 | RDGL

Advanced Medical Isotope research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Ares Capital (ARCC)$14.3B
Blackstone Secured Lending Fund (BXSL)$7B
FS KKR Capital (FSK)$6.2B
Main Street Capital (MAIN)$5.2B
Golub Capital BDC (GBDC)$4B
Hercules Capital (HTGC)$3.3B
Morgan Stanley Direct Lending Fund (MSDL)$1.9B
Goldman Sachs BDC (GSBD)$1.4B
New Mountain Finance (NMFC)$1.2B
Kayne Anderson BDC (KBDC)$1.2B
Bain Capital Specialty Finance (BCSF)$1.1B
BARINGS BDC, INC (BBDC)$1B
Amalgamated Financial (AMAL)$1B
Carlyle Secured Lending (CGBD)$921M
Nuveen Churchill Direct Lending (NCDL)$912M
SLR Investment (SLRC)$893M
Trinity Capital (TRIN)$861M
BLACKROCK TCP CAPITAL CORP (TCPC)$759M
Fidus Investment (FDUS)$723M
Crescent Capital BDC (CCAP)$712M
Gladstone Capital (GLAD)$650M
CION Investment (CION)$610M
Palmer Square Capital BDC (PSBD)$502M
Gladstone Investment (GAIN)$486M
PennantPark Investment (PNNT)$463M
Runway Growth Finance (RWAY)$415M
Stellus Capital Investment (SCM)$376M
Horizon Technology Finance (HRZN)$363M
Saratoga Investment Corp (SAR)$335M
TriplePoint Venture Growth BDC (TPVG)$305M